221 related articles for article (PubMed ID: 7843363)
1. Influenza vaccines: a main problem in control of pandemics.
Ghendon Y
Eur J Epidemiol; 1994 Aug; 10(4):485-6. PubMed ID: 7843363
[TBL] [Abstract][Full Text] [Related]
2. Vaccines for seasonal and pandemic influenza.
Nichol KL; Treanor JJ
J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
[TBL] [Abstract][Full Text] [Related]
3. New technologies for influenza vaccines.
Dormitzer PR; Tsai TF; Del Giudice G
Hum Vaccin Immunother; 2012 Jan; 8(1):45-58. PubMed ID: 22251994
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging cell culture manufacturing technologies for influenza vaccines.
Milián E; Kamen AA
Biomed Res Int; 2015; 2015():504831. PubMed ID: 25815321
[TBL] [Abstract][Full Text] [Related]
5. Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses.
Jin H; Chen Z
Curr Opin Virol; 2014 Jun; 6():34-9. PubMed ID: 24705137
[TBL] [Abstract][Full Text] [Related]
6. Recombinant vaccines for influenza virus.
Tripp RA; Tompkins SM
Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
[TBL] [Abstract][Full Text] [Related]
7. [Progress in new vaccine strategies against influenza: a review].
Liu Z; Jiang T; Qin E; Ran D; Qin C
Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for pandemic influenza.
Luke CJ; Subbarao K
Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
[TBL] [Abstract][Full Text] [Related]
9. Vaccines in development against avian influenza.
Cox MM
Minerva Med; 2007 Apr; 98(2):145-53. PubMed ID: 17519856
[TBL] [Abstract][Full Text] [Related]
10. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
[TBL] [Abstract][Full Text] [Related]
11. Development of live attenuated influenza vaccines against pandemic influenza strains.
Coelingh KL; Luke CJ; Jin H; Talaat KR
Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
13. Selection of influenza vaccine strains and developing pandemic vaccines.
Wood JM
Vaccine; 2002 Dec; 20 Suppl 5():B40-4. PubMed ID: 12477418
[TBL] [Abstract][Full Text] [Related]
14. A pandemic influenza vaccine in India: from strain to sale within 12 months.
Dhere R; Yeolekar L; Kulkarni P; Menon R; Vaidya V; Ganguly M; Tyagi P; Barde P; Jadhav S
Vaccine; 2011 Jul; 29 Suppl 1():A16-21. PubMed ID: 21684421
[TBL] [Abstract][Full Text] [Related]
15. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
[TBL] [Abstract][Full Text] [Related]
16. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
Kreijtz JH; Osterhaus AD; Rimmelzwaan GF
Hum Vaccin; 2009 Mar; 5(3):126-35. PubMed ID: 18948744
[TBL] [Abstract][Full Text] [Related]
17. Influenza vaccines: from whole virus preparations to recombinant protein technology.
Huber VC
Expert Rev Vaccines; 2014 Jan; 13(1):31-42. PubMed ID: 24192014
[TBL] [Abstract][Full Text] [Related]
18. NEW technologies for meeting the global demand for pandemic influenza vaccines.
Fedson DS
Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
[TBL] [Abstract][Full Text] [Related]
19. Pandemic H5N1 influenza vaccine development: an update.
El Sahly HM; Keitel WA
Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
[TBL] [Abstract][Full Text] [Related]
20. Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus.
Carter NJ; Plosker GL
BioDrugs; 2008; 22(5):279-92. PubMed ID: 18778110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
